N-6 and N-3 Fatty Acid Cholesteryl Esters in Relation to Fatal CHD in a Dutch Adult Population: A Nested Case-Control Study and Meta-Analysis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  de Goede, Janette ^a   Verschuren, W M Monique ^b   Boer, Jolanda M A ^b   Verberne, Lisa D M ^a   Kromhout, Daan ^a   Geleijnse, Johanna M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; CHOLESTEROL ESTER; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ARACHIDONIC ACID; CASE-CONTROL STUDIES; CHOLESTEROL ESTERS; CORONARY DISEASE; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LINOLEIC ACID; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; RISK FACTORS;

EID: 84878601795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059408     Document Type: Article

References (34)

1. He K, Song Y, Daviglus ML, Liu K, Van Horn L, et al. (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109: 2705-2711.
2. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, et al. (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71: 179S-188S.
3. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, et al. (2009) Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119: 902-907.
4. Mozaffarian D, Micha R, Wallace S, (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7: e1000252.
5. Zhou L, Nilsson A, (2001) Sources of eicosanoid precursor fatty acid pools in tissues. J Lipid Res 42: 1521-1542.
6. Calder PC, (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107: 1-11.
7. Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC, (2009) alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80: 85-91.
8. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP, (2006) Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84: 44-53.
9. Burdge GC, Calder PC, (2005) Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45: 581-597.
10. Baylin A, Campos H, (2006) The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 17: 22-27.
11. Fekete K, Marosvolgyi T, Jakobik V, Decsi T, (2009) Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89: 2070S-2084S.
12. Willett W (1998) Issues in analysis and presentation of dietary data. In: Willett WC, editor. Nutritional Epidemiology. 2nd ed. New York: Oxford University Press, Inc. 321-346.
13. Arab L, (2003) Biomarkers of fat and fatty acid intake. J Nutr 133Suppl 3: 925S-932S.
14. Zock PL, Mensink RP, Harryvan J, de Vries JH, Katan MB, (1997) Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol 145: 1114-1122.
15. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M, (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38: 2012-2022.
16. Harris WS, Poston WC, Haddock CK, (2007) Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193: 1-10.
17. Rothman KJ, Greenland S (1998) Case control studies. Modern Epidemiology. Philadelphia: Lippincott.
18. Verschuren WMM, Van Leer EM, Blokstra A, (1993) Cardiovascular disease risk factors in the Netherlands. Neth J Cardiol 4: 205-210.
19. Houterman S, Verschuren WM, Oomen CM, Boersma-Cobbaert CM, Kromhout D, (2001) Trends in total and high density lipoprotein cholesterol and their determinants in The Netherlands between 1993 and 1997. Int J Epidemiol 30: 1063-1070.
20. Verschuren WM, Blokstra A, Picavet HS, Smit HA, (2008) Cohort profile: the Doetinchem Cohort Study. Int J Epidemiol 37: 1236-1241.
21. Richardson DB, (2004) An incidence density sampling program for nested case-control analyses. OEM 61: e59-e59.
22. Lubin JH, Gail MH, (1984) Biased selection of controls for case-control analyses of cohort studies. Biometrics 40: 63-75.
23. Glatz JF, Soffers AE, Katan MB, (1989) Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 49: 269-276.
24. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT Jr, et al. (1995) Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 142: 469-476.
25. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ, (1995) A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 25: 387-394.
26. Wang L, Folsom AR, Eckfeldt JH, (2003) Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Nutr Metab Cardiovasc Dis 13: 256-266.
27. Erkkila AT, Lehto S, Pyorala K, Uusitupa MI, (2003) n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 78: 65-71.
28. Warensjo E, Sundstrom J, Vessby B, Cederholm T, Riserus U, (2008) Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 88: 203-209.
29. Greenland S, Longnecker MP, (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135: 1301-1309.
30. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
31. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
32. Matthan NR, Ip B, Resteghini N, Ausman LM, Lichtenstein AH, (2010) Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J Lipid Res 51: 2826-2832.
33. Hodson L, Skeaff CM, Fielding BA, (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47: 348-380.
34. Ma J, Folsom AR, Eckfeldt JH, Lewis L, Chambless LE, (1995) Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 62: 572-578.